Madam Speaker, I appreciate my colleague's question. I will try, in the next few minutes, to give him the exact status of where we are today, the position the government has taken as well as the position of the Minister of Health.
I would like to assure my colleague, and obviously all of my colleagues that are listening, as well as all Canadians, that our government is working with public health officials from the provinces and territories to ensure that in the unlikely event that smallpox were used as a terrorist weapon, we will be prepared to deal with the threat.
These preparations are twofold. The first element consists of a plan. The second element is having a sufficient quantity of smallpox vaccine in Canada. On both of these fronts, we have taken the necessary measures to protect Canadians. Allow me to explain.
There is the Canadian contingency plan for smallpox. We have obviously consulted with the Chief Medical Officers of Health from every province and territory.
This is a very important step because any plan must reflect the way we work together in a real emergency situation. For this reason, Health Canada officials have carefully examined the plan with all of the appropriate provincial and territorial stakeholders, the Chief Medical Officers of Health and their staff, as well as emergency services and emergency social services staff.
The contingency plan has been carefully studied. The final version will soon be released to the public. What does this plan call for?
We have taken the research and confinement approach recommended by the Council of Chief Medical Officers of Health and the World Health Organization. This strategy was applied successfully in the years prior to 1979, and led to the eradication of the disease.
Under this approach, the spread of smallpox is contained by identifying infected persons and any persons who may have contact with them. The vaccine is administered to these people in the four days following their exposure to the smallpox virus, and to those who work with smallpox carriers, health care workers and laboratory workers.
We have been very actively involved in procuring the vaccine. Our intention to get it from a Canadian supplier has been revealed today as part of the government tendering process. Public Works and Government Services Canada issued an advance contract award notice via MERX, the government electronic tendering service.
Our objective is to have a stock of smallpox vaccine available that would be sufficient to react to multiple smallpox outbreaks in Canada, should that event ever occur.
At the same time, we will have the capacity to produce more doses in Canada expeditiously. This would be required if ever we were required to expand the vaccination effort, even to the entire population if circumstances required.
As for the immunoglobulin, which is used to treat serious vaccine side-effects, there is a limited quantity of this in the world, because it is produced from the blood of recently vaccinated individuals, and most countries stopped doing systematic vaccination in 1972.
The United States has recently begin to rebuild its stocks of immunoglobulin, by vaccinating a small number of volunteers who then donate their blood to produce the immunoglobulin. Via discussions with the U.S. Center for Disease Control, Health Canada is taking steps to obtain a certain quantity of the immunoglobulin. I can assure hon. members that Canada has no intention of vaccinating anyone whatsoever against smallpox until this immunoglobulin is available.
This is, obviously, part of our campaign against smallpox, which includes what we call pre-exposure vaccination. Before any outbreak whatsoever occurred, a certain number of individuals would be immunized in order to be in a position to provide medical care to anyone who might be exposed subsequently.
Clearly, we do have a plan and will do everything in our power to implement that plan, if ever the need arises.